Solid tumour trials

We run holistic and complex commercial and non-commercial clinical trials from Phase 1 to Phase 4 in a world class academic and clinical partnership. Our globally recognised clinicians are responsible for trials that are driving cutting-edge novel treatments that advance cancer treatment and care.

Case study: MORab-202

An Early Phase study looking at an antibody to a folate receptor that is expressed in a number of different cancers, linked to a drug that can kill cancer cells.

Case study: ATTEST

A new clinical trial using pioneering virus technology to infect cancer cells and start producing an anti-tumour drug from inside the tumour cells.